<DOC>
	<DOC>NCT01183585</DOC>
	<brief_summary>This single centre, open-label study will investigate the effect of RO4917838 on the pharmacokinetics of Rosuvastatin, a frequently co-prescribed drug in healthy volunteers. Healthy volunteers will receive multiple oral doses of RO4917838 and single oral dose of Rosuvastatin.</brief_summary>
	<brief_title>A Study of RO4917838 With Rosuvastatin in Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Rosuvastatin Calcium</mesh_term>
	<criteria>Adult healthy volunteers, 18 to 65 years of age A body mass index (BMI) between 18 to 30 kg/m2 History of any clinically significant gastrointestinal, renal, hepatic, bronchopulmonary, neurological, psychiatric, cardiovascular, endocrinological, hematological or allergic disease, metabolic disorder, cancer or cirrhosis (Gilbert's Syndrome is allowed) Diseases or medical conditions that are capable of altering the absorption, metabolism or elimination of drugs</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>